Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1991 2
1994 1
1995 2
1999 3
2000 1
2001 2
2002 5
2003 7
2004 11
2005 14
2006 5
2007 4
2008 5
2009 5
2010 5
2011 2
2012 4
2013 7
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 15872342

83 results

Results by year

Filters applied: . Clear all
Page 1
Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone.
Antoniucci D, Migliorini A, Parodi G, Valenti R, Rodriguez A, Hempel A, Memisha G, Santoro GM. Antoniucci D, et al. Circulation. 2004 Apr 13;109(14):1704-6. doi: 10.1161/01.CIR.0000126284.40075.98. Epub 2004 Apr 5. Circulation. 2004. PMID: 15066943 Clinical Trial.
Use of 99mTc-sestamibi gated SPECT to assess the influence of anterograde flow before primary coronary angioplasty on tissue salvage and functional recovery in acute myocardial infarction.
Leoncini M, Bellandi F, Sciagrà R, Maioli M, Toso A, Sestini S, Coppola A, Mennuti A, Dabizzi RP, Pupi A. Leoncini M, et al. Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1378-85. doi: 10.1007/s00259-004-1595-9. Epub 2004 Jun 19. Eur J Nucl Med Mol Imaging. 2004. PMID: 15221297 Clinical Trial.
Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.
Schömig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F, Nekolla SG, Schlotterbeck K, Schühlen H, Pache J, Seyfarth M, Martinoff S, Benzer W, Schmitt C, Dirschinger J, Schwaiger M, Kastrati A; Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators. Schömig A, et al. JAMA. 2005 Jun 15;293(23):2865-72. doi: 10.1001/jama.293.23.2865. JAMA. 2005. PMID: 15956631 Clinical Trial.
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C, Nekolla SG, Seyfarth M, Martinoff S, Markwardt C, Clermont G, Gerbig HW, Leiss J, Schwaiger M, Schömig A; Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators. Kastrati A, et al. JAMA. 2004 Feb 25;291(8):947-54. doi: 10.1001/jama.291.8.947. JAMA. 2004. PMID: 14982910 Clinical Trial.
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schömig A; Stent versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction (STOPAMI-2) Study. Kastrati A, et al. Lancet. 2002 Mar 16;359(9310):920-5. doi: 10.1016/S0140-6736(02)08022-4. Lancet. 2002. PMID: 11918909 Clinical Trial.
83 results